Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Brooklyn ImmunoTherapeutics, Inc.

Brooklyn ImmunoTherapeutics CEO Howard J. Federoff Provides Roadmap for the Company’s Future During May 25, 2021 Shareholder Update Call
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
Tickers BTX
Brooklyn ImmunoTherapeutics Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
Tickers BTX
Michael Andreeff, M.D., Ph.D to Join the Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc.
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
Tickers BTX
Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call Tuesday May 25, 2021 at 4:30 PM ET
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
Tickers BTX
Christopher Rohde, Ph.D. to Join Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc.
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
Brooklyn ImmunoTherapeutics Announces Publication of Results of IRX-2 Monotherapy in Early Stage Breast Cancer in Breast Cancer Research
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
Tickers BTX
Erich Mohr, Ph.D., to Join the Board of Directors of Brooklyn ImmunoTherapeutics
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
Tickers BTX
Matthew During, M.D., Ph.D. to Join the Scientific Advisory Board of Brooklyn ImmunoTherapeutics
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
Tickers BTX
Brooklyn ImmunoTherapeutics Pays $1 Million Towards Acquisition of License for mRNA Technology Platform to Develop Genetically Edited Cells for Multiple Cancers and Blood Disorders
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
Tickers BTX
Dennis H. Langer, M.D., J.D. to Join the Board of Directors of Brooklyn ImmunoTherapeutics, Inc.
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
Tickers BTX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.